Seyyar, M.; Şancı, P.C.; Köşeci, T.; Karakayalı, A.; Akdağ, M.Ö.; Temi, Y.B.; Uygun, K.; Kefeli, U.; Mete, B.; Çabuk, D.
HALP-H Index as a Prognostic Biomarker for Predicting Pathological Complete Response in Early-Stage HER2-Positive Breast Cancer—A Multicenter Retrospective Cohort Study. J. Clin. Med. 2025, 14, 4431.
https://doi.org/10.3390/jcm14134431
AMA Style
Seyyar M, Şancı PC, Köşeci T, Karakayalı A, Akdağ MÖ, Temi YB, Uygun K, Kefeli U, Mete B, Çabuk D.
HALP-H Index as a Prognostic Biomarker for Predicting Pathological Complete Response in Early-Stage HER2-Positive Breast Cancer—A Multicenter Retrospective Cohort Study. Journal of Clinical Medicine. 2025; 14(13):4431.
https://doi.org/10.3390/jcm14134431
Chicago/Turabian Style
Seyyar, Mustafa, Pervin Can Şancı, Tolga Köşeci, Anıl Karakayalı, Mutianur Özkorkmaz Akdağ, Yasemin Bakkal Temi, Kazım Uygun, Umut Kefeli, Burak Mete, and Devrim Çabuk.
2025. "HALP-H Index as a Prognostic Biomarker for Predicting Pathological Complete Response in Early-Stage HER2-Positive Breast Cancer—A Multicenter Retrospective Cohort Study" Journal of Clinical Medicine 14, no. 13: 4431.
https://doi.org/10.3390/jcm14134431
APA Style
Seyyar, M., Şancı, P. C., Köşeci, T., Karakayalı, A., Akdağ, M. Ö., Temi, Y. B., Uygun, K., Kefeli, U., Mete, B., & Çabuk, D.
(2025). HALP-H Index as a Prognostic Biomarker for Predicting Pathological Complete Response in Early-Stage HER2-Positive Breast Cancer—A Multicenter Retrospective Cohort Study. Journal of Clinical Medicine, 14(13), 4431.
https://doi.org/10.3390/jcm14134431
